Erratum: Adenoviral Gene Transfer of PLD1-D4 Enhances Insulin Sensitivity in Mice by Disrupting Phospholipase D1 Interaction with PED/PEA-15 (PLoS ONE (2013) 8: 4 (e60555) DOI: 10.1371/journal.pone.0060555);Adenoviral Gene Transfer of PLD1-D4 Enhances Insulin Sensitivity in Mice by Disrupting Phospholipase D1 Interaction with PED/PEA-15

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Cassese, Angela ^a   Raciti, Gregory A ^a   Fiory, Francesca ^a   Nigro, Cecilia ^a   Ulianich, Luca ^a   Castanò, Ilenia ^a,b   D'Esposito, Vittoria ^a   Terracciano, Daniela ^a   Pastore, Lucio ^a,b   Formisano, Pietro ^a   Beguinot, Francesco ^a   Miele, Claudia ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b CEINGE BIOTECNOLOGIE AVANZATE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; COMPLEMENTARY DNA; FATTY ACID; GLUCOSE; INSULIN; MESSENGER RNA; PHOSPHOLIPASE D1; PHOSPHOLIPASE D1 D4 DOMAIN; PHOSPHOPROTEIN; PHOSPHOPROTEIN ENRICHED IN ASTROCYTE 15; PROTEIN KINASE C ALPHA; PROTEIN KINASE C ZETA; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DISSOCIATION; DRUG EFFICACY; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FATTY ACID BLOOD LEVEL; FEMALE; GENE OVEREXPRESSION; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE; GLUCOSE TRANSPORT; HUMAN; IN VITRO GENE TRANSFER; IN VIVO GENE TRANSFER; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID DIET; MALE; MOUSE; NONHUMAN; OBESITY; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RAT; TRANSGENIC MOUSE; VIRAL GENE DELIVERY SYSTEM;

EID: 84876013844     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0263951     Document Type: Erratum

References (30)

1. Malecki MT, Klupa T, (2005) Type 2 diabetes mellitus: from genes to disease. Pharmacol Rep 57: 20-32.
2. Gan D (2006) Diabetes Atlas 2006, 3rd ed. Brussels: International Diabetes Federation.
3. Zimmet P, Alberti KG, Shaw J, (2001) Global and societal implications of the diabetes epidemic. Nature 414: 782-787.
4. Condorelli G, Vigliotta G, Iavarone C, Caruso M, Tocchetti CG, et al. (1998) PED/PEA-15 gene controls glucose transport and is overexpressed in type 2 diabetes mellitus. EMBO J 17: 3858-3866.
5. Valentino R, Lupoli GA, Raciti GA, Oriente F, Marinaro E, et al. (2006) The PEA15 gene is overexpressed and related to insulin resistance in healthy first-degree relatives of patients with type 2 diabetes. Diabetologia 49: 3058-3066.
6. Vigliotta G, Miele C, Santoprietro S, Portella G, Perfetti A, et al. (2004) Overexpression of the ped/pea-15 gene causes diabetes by impairing glucose-stimulated insulin secretion in addition to insulin action. Mol Cell Biol 24: 5005-5015.
7. Condorelli G, Vigliotta G, Trencia A, Maitan MA, Caruso M, et al. (2001) Protein kinase C (PKC)-alpha activation inhibits PKC-zeta and mediates the action of PED/PEA-15 on glucose transport in the L6 skeletal muscle cells. Diabetes 50: 1244-1252.
8. Zhang Y, Redina O, Altshuller YM, Yamazaki M, Ramos J, et al. (2000) Regulation of expression of phospholipase D1 and D2 by PEA-15, a novel protein that interacts with them. J Biol Chem 275: 35224-35232.
9. Viparelli F, Cassese A, Doti N, Paturzo F, Marasco D, et al. (2008) Phospholipase D1 enhances insulin sensitivity in skeletal muscle cells. J Biol Chem 283: 21769-21778.
10. He TC, Zhou S, Da Costa LT, Yu J, Kinzler KW, et al. (1998) A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci 95: 2509-2514.
11. Raciti GA, Iadicicco C, Ulianich L, Vind BF, Gaster M, et al. (2010) Glucosamine-induced endoplasmic reticulum stress affects GLUT4 expression via activating transcription factor 6 in rat and human skeletal muscle cells. Diabetologia 53: 955-965.
12. Raciti GA, Bera TK, Gavrilova O, Pastan I, (2011) Partial inactivation of Ankrd26 causes diabetes with enhanced insulin responsiveness of adipose tissue in mice. Diabetologia 54: 2911-2922.
13. Miele C, Raciti GA, Cassese A, Romano C, Giacco F, et al. (2007) PED/PEA-15 regulates glucose-induced insulin secretion by restraining potassium channel expression in pancreatic beta-cells. Diabetes 56: 622-633.
14. Ungaro P, Mirra P, Oriente F, Nigro C, Ciccarelli M, et al. (2012) Peroxisome Proliferator-activated Receptor-γ Activation Enhances Insulin-stimulated Glucose Disposal by Reducing ped/pea-15 Gene Expression in Skeletal Muscle Cells: evidence for involvement of activator protein-1. J Biol Chem 287: 42951-42961.
15. DeFronzo RA, (2010) Current issues in the treatment of type 2 diabetes. Overview of newer agents: where treatment is going. Am J Med 123: S38-48.
16. Bandyopadhyay G, Standaert ML, Kikkawa U, Ono Y, Moscat J, et al. (1999) Effects of transiently expressed atypical (ζ, λ), conventional (α, β) and novel (δ, ε) protein kinase C isoforms on insulin-stimulated translocation of epitope-tagged GLUT4 glucose transporters in rat adipocytes: specific interchangeable effects of protein kinases C-ζ and C-λ. Biochem J 337: 461-470.
17. Bandyopadhyay G, Standaert ML, Galloway L, Moscat J, Farese RV, (1997) Evidence for involvement of protein kinase C (PKC)-ζ and noninvolvement of diacylglycerol-sensitive PKCs in insulin-stimulated glucose transport in L6 myotubes. Endocrinology 138: 4721-4731.
18. Leitges M, Plomann M, Standaert ML, Bandyopadhyay G, Sajan MP, et al. (2002) Knockout of PKC alpha enhances insulin signaling through PI3K. Mol Endocrinol 16: 847-858.
19. Coussens L, Parker PJ, Rhee L, Yang-Feng TL, Chen E, et al. (1986) Multiple, distinct forms of bovine and human protein kinase C suggest diversity in cellular signaling pathways. Science 233: 859-866.
20. McDermott M, Wakelam MJ, Morris AJ, (2004) Phospholipase D. Biochem Cell Biol. 82: 225-253.
21. Geraldes P, King GL, (2010) Activation of protein kinase C isoforms and its impact on diabetic complications. Circ Res 106: 1319-1331.
22. Cerreto M, Mehdawy B, Ombrone D, Nisticò R, Ruoppolo M, et al. (2012) Reversal of metabolic and neurological symptoms of phenylketonuric mice treated with a PAH containing helper-dependent adenoviral vector. Curr Gene Ther. 12: 48-56.
23. Pastore L, Belalcazar LM, Oka K, Cela R, Lee B, et al. (2004) Helper-dependent adenoviral vector-mediated long-term expression of human apolipoprotein A-I reduces atherosclerosis in apo E-deficient mice. Gene 327: 153-160.
24. Doti N, Cassese A, Marasco D, Paturzo F, Sabatella M, et al. (2010) Residues 762-801 of PLD1 mediate the interaction with PED/PEA15. Mol Biosyst 6: 2039-2048.
25. McDermott M, Wakelam MJ, Morris AJ, (2004) Phospholipase D. Biochem Cell Biol. 82: 225-253.
26. Brown HA, Gutowski S, Moomaw CR, Slaughter C, Sternweis PC, (1993) ADP-ribosylation factor, a small GTP-dependent regulatory protein, stimulates phospholipase D activity. Cell 75: 1137-1144.
27. Cockcroft S, Thomas GM, Fensome A, Geny B, Cunningham E, et al. (1994) Phospholipase D: a downstream effector of ARF in granulocytes. Science 263: 523-526.
28. Singer WD, Brown HA, Jiang X, Sternweis PC, (1996) Regulation of phospholipase D by protein kinase C is synergistic with ADP-ribosylation factor and independent of protein kinase activity. J Biol Chem 271: 4504-4510.
29. Malcolm KC, Ross AH, Qiu RG, Symons M, Exton JH, (1994) Activation of rat liver phospholipase D by the small GTP-binding protein RhoA. J Biol Chem 1994 269: 25951-25954.
30. Kuribara H, Tago K, Yokozeki T, Sasaki T, Takai Y, et al. (1995) Synergistic activation of rat brain phospholipase D by ADP-ribosylation factor and rhoA p21, and its inhibition by Clostridium botulinum C3 exoenzyme. J Biol Chem 270: 25667-25671.